Prostate Cancer Therapy

Abiraterone

Androgen biosynthesis inhibitor for advanced prostate cancer treatment.

Abiraterone is a prescription medication used to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting CYP17, an enzyme involved in androgen production, thereby reducing levels of testosterone and other androgens that can stimulate prostate cancer growth. Abiraterone is used in combination with prednisone to improve survival outcomes in men with advanced prostate cancer.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers

  • Significantly extends overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) when combined with prednisone

  • Reduces tumor burden and delays disease progression by inhibiting androgen production at all three sources: testes, adrenal glands, and tumor tissue

  • Lowers prostate-specific antigen (PSA) levels effectively, indicating reduced cancer activity

  • Improves radiographic progression-free survival, delaying worsening seen on imaging studies

  • Enhances quality of life by reducing cancer-related symptoms such as bone pain and fatigue

  • Well tolerated with manageable side effects under medical supervision

  • Abiraterone acetate: generic for Zytiga; an androgen biosynthesis inhibitor that blocks CYP17 enzyme activity, decreasing androgen production from the testes, adrenal glands, and prostate tumor tissue

  • Take four 250mg tablets (total 1000mg) by mouth once daily

  • Take on an empty stomach, at least one hour before or two hours after food

  • Swallow tablets whole with water; do not crush or chew

  • Must be taken in combination with prednisone, as prescribed by your doctor, to reduce risk of adrenal side effects

  • Take doses at the same time each day for optimal effectiveness

  • Continue treatment unless your provider instructs otherwise, even if you feel well